MedTrace Logo

Study on the Mechanism of Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene Mutation

NCT03587155 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-07-16

No results posted yet for this study

Summary

The investigators propose to analyze a brain sample and/or peripheral blood by single cell RNA seq from aborted embryos with ASNS mutation.

Conditions

  • Asparagine Synthetase Deficiency
  • Genetic Diseases, Inborn

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • The First Hospital of Jilin University

    lead OTHER

Principal Investigators

  • Bo Chen, M.D., Ph.D. · The First Hospital of Jilin University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-28
Primary Completion
2018-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03587155 on ClinicalTrials.gov